APA (7th ed.) Citation

Lyons, S., Bennett, K., Cousins, G., Durand, L., O'Hara, A., Crowley, D., & Keenan, E. Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: Protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023 [version 2; peer review: 1 approved, 2 approved with reservations]. F1000 Research Ltd.

Chicago Style (17th ed.) Citation

Lyons, Suzi, Kathleen Bennett, Gráinne Cousins, Louise Durand, Andy O'Hara, Des Crowley, and Eamon Keenan. Impact of Guidance Issued During COVID-19 to Expand Take-home Doses of Opioid Agonist Treatment (OAT) in Ireland: Protocol for a Population-based Analysis of Prescribing Practices and Patient Outcomes 2018 to 2023 [version 2; Peer Review: 1 Approved, 2 Approved with Reservations]. F1000 Research Ltd.

MLA (9th ed.) Citation

Lyons, Suzi, et al. Impact of Guidance Issued During COVID-19 to Expand Take-home Doses of Opioid Agonist Treatment (OAT) in Ireland: Protocol for a Population-based Analysis of Prescribing Practices and Patient Outcomes 2018 to 2023 [version 2; Peer Review: 1 Approved, 2 Approved with Reservations]. F1000 Research Ltd.